Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| May 6, 2016 | ACT Genomics | $12.5M Series B | CDIB Capital, Hotung Venture Group | Hua Nan Venture Capital, President International Development Corporation, UMC Capital |
| Aug 9, 2007 | Nereus Pharmaceuticals | $45.0M Series D | BankInvest Biomedical Venture | Advent International, Alta Partners, Astellas Venture Management, Boston Life Science Venture Corporation, Forward Ventures, Gimv, HBM Healthcare Investments, InterWest Partners, Pacific Venture Group, Roche, Taiwan Global Biofund |